Clinical Research

Contact Us

A large and growing body of scientific research links rapid eating with overweight and obesity in many cases.  Over the past seven years, a great deal of academic and IRB approved clinical research has been conducted on Sensor Monitored Alimentary Restriction Therapy (SMART™) to validate the clinical effectiveness and safety of our device.  As part of this process, Scientific Intake has developed relationships with thought leaders around the world, including at Harvard, Yale, Lenox Hill Hospital, Monash University Medical School Australia, Imperial College of London and the prestigious Pennington Biomedical Center at LSU to incorporate their expertise into the development of SMART™.  In addition to those studies summarized here, there are other studies that support the link between eating rate and controlling weight.

As members of NAASO (North American Association for the Study of Obesity), we are proud to note that research on SMART™ and how rapid eating leads to obesity has been published in the Obesity Research journal and presented after peer review at the NAASO Annual Meeting.

A few highlights of the findings on Sensor Monitored Alimentary Restriction Therapy:

• SMART™ users reduced their daily food intake by 23%.
• SMART subjects consumed 533 fewer calories over the course of a day.
• SMART users ate less but did not get hungry sooner than non-SMART users.
• Excess body weight loss (the difference between ideal weight and actual weight) averaged 38.1% among subjects who used the device as directed.  Study participants that used the device as directed averaged 8% total body weight loss in four (4) months.

Over the past decade, many epidemiological and laboratory studies have linked rising overweight and obesity with rate of food intake.  See Science & Research for further information.

 

 

Updated 8/4/2009

© 2012 Scientific Intake Limited Co.